Baseline Characteristics of a Patient Cohort and Predictors of In-hospital MORtality in CORonary Care Units (MORCOR-TURK) Trial in Türkiye.

Türkiye'de Koroner Yoğun Bakım Ünitelerindeki Hastane İçi Mortalite (MORCOR-TURK) Çalışmasında Hasta Temel Karakteristikleri ve Öngördürücüleri.

Journal

Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir
ISSN: 1308-4488
Titre abrégé: Turk Kardiyol Dern Ars
Pays: Turkey
ID NLM: 9426239

Informations de publication

Date de publication:
Apr 2024
Historique:
medline: 5 4 2024
pubmed: 4 4 2024
entrez: 4 4 2024
Statut: ppublish

Résumé

The MORtality in CORonary Care Units in Türkiye (MORCOR-TURK) trial is a national registry evaluating predictors and rates of in-hospital mortality in coronary care unit (CCU) patients in Türkiye. This report describes the baseline demographic characteristics of patients recruited for the MORCOR-TURK trial. The study is a multicenter, cross-sectional, prospective national registry that included 50 centers capable of 24-hour CCU service, selected from all seven geographic regions of Türkiye. All consecutive patients admitted to CCUs with cardiovascular emergencies between September 1-30, 2022, were prospectively enrolled. Baseline demographic characteristics, admission diagnoses, laboratory data, and cardiovascular risk factors were recorded. A total of 3,157 patients with a mean age of 65 years (range: 56-73) and 2,087 (66.1%) males were included in the analysis. Patients with arterial hypertension [1,864 patients (59%)], diabetes mellitus (DM) [1,184 (37.5%)], hyperlipidemia [1,120 (35.5%)], and smoking [1,093 (34.6%)] were noted. Non-ST elevation myocardial infarction (NSTEMI) was the leading cause of admission [1,187 patients (37.6%)], followed by ST elevation myocardial infarction (STEMI) in 742 patients (23.5%). Other frequent diagnoses included decompensated heart failure (HF) [339 patients (10.7%)] and arrhythmia [272 patients (8.6%)], respectively. Atrial fibrillation (AF) was the most common pathological rhythm [442 patients (14%)], and chest pain was the most common primary complaint [2,173 patients (68.8%)]. The most common admission diagnosis was acute coronary syndrome (ACS), particularly NSTEMI. Hypertension and DM were found to be the two leading risk factors, and AF was the most commonly seen pathological rhythm in all hospitalized patients. These findings may be useful in understanding the characteristics of patients admitted to CCUs and thus in taking precautions to decrease CCU admissions.

Identifiants

pubmed: 38573092
doi: 10.5543/tkda.2023.67505
doi:

Types de publication

Clinical Trial Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

175-181

Auteurs

Ahmet Seyda Yılmaz (AS)

Recep Tayyip Erdogan University, Faculty of Medicine, Department of Cardiology, Rize, Turkiye.

Fatih Kahraman (F)

Kütahya Evliya Çelebi Training and Research Hospital, Department of Cardiology, Kütahya, Turkiye.

İbrahim Ersoy (İ)

Afyonkarahisar Science of Health University, Department of Cardiology, Afyon, Turkiye.

Gökay Taylan (G)

Trakya University, Department of Cardiology, Tekirdağ, Turkiye.

Emin Erdem Kaya (EE)

Ersin Arslan Training and Research Hospital, Department of Cardiology, Gaziantep, Turkiye.

Ertan Aydın (E)

Giresun University, Department of Cardiology, Giresun, Turkiye.

Muammer Karakayalı (M)

Kafkas University Training and Research Hospital, Department of Cardiology, Kars, Turkiye.

Muhammet Mürsel Öğütveren (MM)

Recep Tayyip Erdogan University, Faculty of Medicine, Department of Cardiology, Rize, Turkiye.

Aybike Gül Taşdelen (AG)

İstanbul Cardiology Institute, Department of Cardiology, Istanbul, Turkiye.

Ömer Kümet (Ö)

Van Training and Research Hospital, Department of Cardiology, Van, Turkiye.

Murat Gül (M)

Aksaray University, Department of Cardiology, Aksaray, Turkiye.

Serdar Gökhan Nurkoç (SG)

Yozgat City Hospital, Department of Cardiology, Yozgat, Turkiye.

Şeyhmus Atan (Ş)

Ankara University, Faculty of Medicine, Department of Cardiology, Ankara, Turkiye.

Mehmet Özgeyik (M)

Eskişehir City Hospital, Department of Cardiology, Eskişehir, Turkiye.

Oğuz Kılıç (O)

Karaman Training and Research Hospital, Department of Cardiology, Karaman, Turkiye.

Aslıhan Merve Toprak (AM)

Selçuk University, Faculty of Medicine, Department of Cardiology, Konya, Turkiye.

Mehmet Özbek (M)

Dicle University, Faculty of Medicine, Department of Cardiology, Diyarbakır, Turkiye.

Ömer Kertmen (Ö)

Amasya Training and Research Hospital, Department of Cardiology, Amasya, Turkiye.

Özgen Şafak (Ö)

Balıkesir University, Faculty of Medicine, Department of Cardiology, Balıkesir, Turkiye.

Gurbet Özge Mert (GÖ)

Osmangazi University, Faculty of Medicine, Department of Cardiology, Eskişehir, Turkiye.

Mevlüt Demir (M)

Kütahya Evliya Çelebi Training and Research Hospital, Department of Cardiology, Kütahya, Turkiye.

Yunus Emre Yavuz (YE)

Siirt Training and Research Hospital, Department of Cardiology, Siirt, Turkiye.

Şaban Keleşoğlu (Ş)

Erciyes University, Faculty of Medicine, Department of Cardiology, Kayseri, Turkiye.

Melisa Uçar (M)

Samsun Training and Research Hospital, Department of Cardiology, Samsun, Turkiye.

İsmail Barkın Işık (İB)

Rize State Hospital, Department of Cardiology, Rize, Turkiye.

Can Ramazan Öncel (CR)

Alanya Alaaddin Keykubat University, Department of Cardiology, Antalya, Turkiye.

Muhammed Erkam Cengil (ME)

Osmaniye State Hospital, Department of Cardiology, Adana, Turkiye.

Uğur Küçük (U)

Çanakkale 18 Mart University, Department of Cardiology, Çanakkale, Turkiye.

Ferhat Dindaş (F)

Uşak Training and Research Hospital, Department of Cardiology, Uşak, Turkiye.

Meltem Altınsoy (M)

Ankara Etlik City Hospital, Department of Cardiology, Ankara, Turkiye.

Fatih Akkaya (F)

Ordu University, Faculty of Medicine, Department of Cardiology, Ordu, Turkiye.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH